Dianthus Therapeutics, Inc. (DNTH)
105.84
-5.70
(-5.11%)
USD |
NASDAQ |
Aug 28, 16:00
103.73
-2.11
(-1.99%)
After-Hours: 20:00
Dianthus Therapeutics Cash from Investing (Quarterly) : -478.52M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -478.52M |
| March 31, 2026 | -133.97M |
| December 31, 2025 | 37.20M |
| September 30, 2025 | -201.28M |
| June 30, 2025 | 26.44M |
| March 31, 2025 | 14.79M |
| December 31, 2024 | -23.11M |
| September 30, 2024 | -259.36M |
| June 30, 2024 | 1.169M |
| March 31, 2024 | -5.507M |
| December 31, 2023 | -8.237M |
| September 30, 2023 | -11.50M |
| June 30, 2023 | 21.86M |
| March 31, 2023 | 18.13M |
| December 31, 2022 | -12.66M |
| September 30, 2022 | -6.881M |
| June 30, 2022 | -0.129M |
| March 31, 2022 | -40.14M |
| December 31, 2021 | -10.32M |
| Date | Value |
|---|---|
| September 30, 2021 | 16.37M |
| June 30, 2021 | 29.89M |
| March 31, 2021 | 7.493M |
| December 31, 2020 | -70.97M |
| September 30, 2020 | 19.98M |
| June 30, 2020 | 14.96M |
| March 31, 2020 | 25.40M |
| December 31, 2019 | -5.723M |
| September 30, 2019 | 63.81M |
| June 30, 2019 | -43.82M |
| March 31, 2019 | -12.73M |
| December 31, 2018 | -86.61M |
| September 30, 2018 | -2.475M |
| June 30, 2018 | -2.453M |
| March 31, 2018 | -0.161M |
| December 31, 2017 | -0.182M |
| September 30, 2017 | -0.385M |
| June 30, 2017 | -1.066M |
| March 31, 2017 | -0.566M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Legend Biotech Corp. | -120.10M |
| Ironwood Pharmaceuticals, Inc. | 0.00 |
| Verastem, Inc. | 16.25M |
| Fortress Biotech, Inc. | -0.079M |
| AbbVie, Inc. | -1.197B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -48.98M |
| Cash from Financing (Quarterly) | 10.38M |
| Free Cash Flow | -155.71M |
| Free Cash Flow Per Share (Quarterly) | -0.8774 |
| Free Cash Flow to Equity (Quarterly) | -49.08M |
| Free Cash Flow to Firm (Quarterly) | -49.16M |
| Free Cash Flow Yield | -3.15% |